Clinical Trial Update: A Study of CM310 in Subjects With Chronic Pruritus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CM310 in chronic pruritus of unknown origin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus of Unknown Origin

Drugs mentioned

• CM310

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Chronic Pruritus of Unknown Origin | Phase 2 | Status: UNKNOWN